PRE Prenetics Global Limited

  1. Stocks
  2. Healthcare
  3. NASDAQ: PRE

Price (delayed)

$19.92

Market cap

$338.29M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.29

Enterprise value

$282.73M

?
Relative Growth: Rel. Growth: 63
Relative Strength: Rel. Strength: 82
Relative Valuation: Rel. Valuation: 16
Relative Profitability: Rel. Profitability: 26
Highlights
The debt has dropped by 85% year-on-year and by 74% since the previous quarter
The quick ratio has surged by 83% since the previous quarter and by 48% year-on-year
PRE's EPS is down by 23% since the previous quarter but it is up by 14% year-on-year
The gross margin rose by 13% since the previous quarter but it has declined by 4% year-on-year
Prenetics Global Limited's net income has decreased by 34% QoQ and by 4.8% YoY
The equity has declined by 25% year-on-year and by 23% since the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Peers: AXS AIG

Key stats

What are the main financial stats of PRE

PRE stock price

How has the Prenetics Global Limited stock price performed over time
Intraday
-0.2%
1 week
-2.88%
1 month
18.78%
1 year
145.01%
YTD
26.48%
QTD
3.11%

Financial performance

How have Prenetics Global Limited's revenue and profit performed over time
Revenue
$107.76M
Gross profit
$64.52M
Operating income
-$34.34M
Net income
-$50.42M
Gross margin
59.9%
Net margin
-46.8%
The net margin has surged by 83% year-on-year but it has declined by 15% since the previous quarter
Prenetics Global Limited's operating margin has soared by 83% YoY and by 34% from the previous quarter
Prenetics Global Limited's net income has decreased by 34% QoQ and by 4.8% YoY
Prenetics Global Limited's gross profit has increased by 32% QoQ

Price vs fundamentals

How does PRE's price correlate with its fundamentals

Growth

What is Prenetics Global Limited's growth rate over time

Valuation

What is Prenetics Global Limited stock price valuation
P/E
N/A
P/B
2.64
P/S
3.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.62
PRE's EPS is down by 23% since the previous quarter but it is up by 14% year-on-year
The price to book (P/B) is 193% more than the 5-year quarterly average of 0.9 and 89% more than the last 4 quarters average of 1.4
The equity has declined by 25% year-on-year and by 23% since the previous quarter
PRE's revenue is up by 17% from the previous quarter

Efficiency

How efficient is Prenetics Global Limited business performance
PRE's return on sales has surged by 85% year-on-year but it is down by 14% since the previous quarter
PRE's ROIC is down by 44% from the previous quarter but it is up by 26% YoY
The ROE has contracted by 43% from the previous quarter and by 24% YoY
The return on assets has declined by 39% since the previous quarter and by 20% year-on-year

Dividends

What is PRE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PRE.

Financial health

How did Prenetics Global Limited financials performed over time
The quick ratio has surged by 83% since the previous quarter and by 48% year-on-year
Prenetics Global Limited's current ratio has surged by 73% QoQ and by 42% YoY
The debt is 100% smaller than the equity
Prenetics Global Limited's debt to equity has plunged by 100% from the previous quarter and by 100% YoY
The debt has dropped by 85% year-on-year and by 74% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.